Compare Sanofi SA (SNY) vs Unilever plc (UL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Sanofi SA vs Unilever plc — how do they compare? Sanofi SA trades at $44.05 (market cap $104.83B), while Unilever plc trades at $62.18 (market cap $131.86B). The key difference: Unilever plc is the larger of the two by market cap, and Sanofi SA pays the higher dividend (5.5%). Which is the better fit depends on your goals.
| SNY | UL | |
|---|---|---|
Market Cap | $104.83B | $131.86B |
Sector | Health | Consumer Staples |
52-Week High | $52.34 | $74.59 |
52-Week Low | $41.33 | $55.05 |
Enterprise Value | $121.32B | $157.31B |
Dividend Yield | 5.5% | 3.68% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Sanofi SA
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
Read more on SNY →About Unilever plc
Unilever is a diversified personal product (42% of 2021 sales by value), home care (20%), and packaged food (38%) company. Its brands include Knorr soups and sauces, Hellmann's mayonnaise, Lipton teas, Axe and Dove skin products, and the TRESemme haircare brand. The firm has been acquisitive in recent years
Read more on UL →
